Salim Yazji, Chief Medical Officer at Oncternal Therapeutics, Inc. (ONCT), bought 25,000 shares at $0.29 ($7K) on 2023-04-13, disclosed to the SEC on 2023-04-14.
Open-market purchase of $7k ONCT by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.29 | 10,000 | $3K | 39.7% |
| 2 | $0.29 | 10,000 | $3K | 39.7% |
| 3 | $0.30 | 5,000 | $2K | 20.5% |
| Total | $0.29 avg | 25,000 | $7K | 100% |